Home / HLA-DRB3 Knockout Cell Lines

HLA-DRB3 Knockout Cell Lines

Gene: HLA-DRB3

Official Full Name: major histocompatibility complex, class II, DR beta 3provided by HGNC

Gene Summary: HLA-DRB3 belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DRA) and a beta (DRB) chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells. The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. There are multiple pseudogenes of this gene. [provided by RefSeq, Feb 2020]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO37338 HLA-DRB3 Knockout cell line (HeLa) Human HLA-DRB3 1:3~1:6 Negative Online Inquiry
KO37339 HLA-DRB3 Knockout cell line (HCT 116) Human HLA-DRB3 1:2~1:4 Negative Online Inquiry
KO37340 HLA-DRB3 Knockout cell line (HEK293) Human HLA-DRB3 1:3~1:6 Negative Online Inquiry
KO37341 HLA-DRB3 Knockout cell line (A549) Human HLA-DRB3 1:3~1:4 Negative Online Inquiry

Background

HLA-DRB3 Gene Knockout Cell Lines are genetically engineered cell lines in which the HLA-DRB3 gene has been selectively disrupted, providing a powerful tool for researchers studying immune response, transplantation biology, and autoimmune diseases. By completely knocking out this gene, which is essential for the expression of MHC class II molecules, these cell lines facilitate the investigation of antigen presentation mechanisms and T cell activation processes.

The primary mechanism by which HLA-DRB3 knockout cell lines function is their ability to create a controlled environment devoid of HLA-DRB3 expression. This allows researchers to examine the role of HLA-DRB3 in immune responses without interference from its activity. For example, these cell lines can be utilized in studies of T cell recognition, B cell activation, and the development of therapeutics targeting autoimmune diseases where HLA-DRB3 is implicated.

The scientific significance of HLA-DRB3 knockout cell lines extends across various fields. In clinical research, they are indispensable for developing and testing new immunotherapies, understanding transplant rejection mechanisms, and investigating the genetics behind susceptibility to autoimmune disorders. Furthermore, they serve as essential models in drug discovery, particularly for drugs aimed at modulating immune responses.

Compared to traditional models, HLA-DRB3 knockout cell lines offer specific advantages, including precise control over genetic expression, the ability to mimic pathological conditions more accurately, and a higher throughput in experimental designs. This allows for more robust and reproducible results, which are paramount in both academic and pharmaceutical research settings.

For researchers and clinicians, the utilization of HLA-DRB3 knockout cell lines represents a promising avenue to unravel complex immune interactions, leading to better-targeted therapies and improved patient outcomes. Our company is at the forefront of providing high-quality biological products, supported by years of expertise in genetic engineering and cell line development, ensuring you have the best tools available for your research endeavors.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.